A detailed history of Premier Fund Managers LTD transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Premier Fund Managers LTD holds 250,000 shares of CRL stock, worth $47.3 Million. This represents 1.76% of its overall portfolio holdings.

Number of Shares
250,000
Previous 160,000 56.25%
Holding current value
$47.3 Million
Previous $33.2 Million 49.37%
% of portfolio
1.76%
Previous 1.33%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$187.96 - $245.29 $16.9 Million - $22.1 Million
90,000 Added 56.25%
250,000 $49.6 Million
Q1 2024

May 13, 2024

SELL
$203.52 - $273.43 $8.95 Million - $12 Million
-44,000 Reduced 21.57%
160,000 $43.1 Million
Q4 2023

Feb 13, 2024

SELL
$164.52 - $238.84 $2.63 Million - $3.82 Million
-16,000 Reduced 7.27%
204,000 $48.7 Million
Q4 2022

Feb 09, 2023

BUY
$197.11 - $250.07 $29.6 Million - $37.6 Million
150,211 Added 215.24%
220,000 $49.2 Million
Q4 2022

Feb 08, 2023

SELL
$197.11 - $250.07 $8.12 Million - $10.3 Million
-41,211 Reduced 37.13%
69,789 $730,000
Q3 2022

Nov 04, 2022

BUY
$182.44 - $250.54 $12.8 Million - $17.5 Million
70,000 Added 170.73%
111,000 $21.1 Million
Q1 2022

May 10, 2022

SELL
$255.51 - $362.11 $10 Million - $14.2 Million
-39,300 Reduced 48.94%
41,000 $11.9 Million
Q4 2021

Feb 14, 2022

SELL
$351.38 - $448.68 $5.69 Million - $7.27 Million
-16,200 Reduced 16.79%
80,300 $30.2 Million
Q3 2021

Nov 10, 2021

SELL
$372.64 - $458.3 $335,376 - $412,470
-900 Reduced 0.92%
96,500 $40.9 Million
Q2 2021

Aug 05, 2021

BUY
$294.17 - $371.65 $1.71 Million - $2.16 Million
5,800 Added 6.33%
97,400 $36.2 Million
Q2 2020

Aug 13, 2020

BUY
$118.84 - $189.72 $10.9 Million - $17.4 Million
91,600 New
91,600 $16 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.63B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Premier Fund Managers LTD Portfolio

Follow Premier Fund Managers LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Premier Fund Managers LTD, based on Form 13F filings with the SEC.

News

Stay updated on Premier Fund Managers LTD with notifications on news.